IRIS
AMICOSANTE, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.079
EU - Europa 2.980
AS - Asia 2.859
SA - Sud America 397
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 3
Totale 36.364
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.026
SG - Singapore 1.458
DE - Germania 1.077
CN - Cina 672
UA - Ucraina 393
BR - Brasile 329
RU - Federazione Russa 293
IE - Irlanda 254
IT - Italia 244
FR - Francia 224
HK - Hong Kong 224
VN - Vietnam 221
GB - Regno Unito 115
SE - Svezia 115
FI - Finlandia 111
KR - Corea 86
JP - Giappone 53
IN - India 40
PL - Polonia 40
CA - Canada 34
AR - Argentina 27
RO - Romania 27
BE - Belgio 16
ZA - Sudafrica 16
EC - Ecuador 15
AT - Austria 13
MX - Messico 13
BD - Bangladesh 11
BG - Bulgaria 11
ES - Italia 11
ID - Indonesia 11
IQ - Iraq 11
NL - Olanda 10
CO - Colombia 9
KG - Kirghizistan 9
TR - Turchia 9
CL - Cile 8
EU - Europa 8
IL - Israele 7
UZ - Uzbekistan 7
TH - Thailandia 6
EG - Egitto 4
KE - Kenya 4
MY - Malesia 4
PE - Perù 4
PH - Filippine 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
JO - Giordania 3
LB - Libano 3
LT - Lituania 3
MA - Marocco 3
SA - Arabia Saudita 3
VE - Venezuela 3
AL - Albania 2
DK - Danimarca 2
DM - Dominica 2
HU - Ungheria 2
IR - Iran 2
IS - Islanda 2
MD - Moldavia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
TW - Taiwan 2
ZM - Zambia 2
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BS - Bahamas 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
GY - Guiana 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SI - Slovenia 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 36.364
Salva come PNG Salva come JPEG
Città #
Woodbridge 9.446
Wilmington 7.870
Houston 7.304
Ann Arbor 714
Fairfield 655
Singapore 628
Ashburn 419
Jacksonville 374
Chandler 302
Beijing 301
San Jose 288
Seattle 282
Dublin 244
Cambridge 219
Hong Kong 219
Medford 186
Dearborn 152
New York 111
Santa Clara 89
Lawrence 87
The Dalles 70
Ho Chi Minh City 68
Menlo Park 63
Los Angeles 60
Rome 60
Hanoi 57
Lauterbourg 55
Dallas 53
Zhengzhou 53
Council Bluffs 43
Tokyo 42
Buffalo 38
Guangzhou 37
Milan 33
Mülheim 27
San Diego 27
Kraków 25
São Paulo 25
Helsinki 23
Norwalk 20
Redondo Beach 20
Moscow 19
Chicago 18
Shanghai 18
Nanjing 17
Boardman 16
London 15
Munich 15
Brussels 14
Falls Church 14
Mountain View 14
Rio de Janeiro 14
Hefei 13
Orem 13
Palo Alto 13
Denver 12
Nuremberg 12
University Park 12
Warsaw 12
Frankfurt am Main 11
San Mateo 11
Verona 11
Johannesburg 10
Montreal 10
San Francisco 10
Stockholm 10
Atlanta 9
Chennai 9
Redwood City 9
Sofia 9
Belo Horizonte 8
Columbus 8
Da Nang 8
Haiphong 7
Mcallen 7
Mumbai 7
Nanchang 7
North Bergen 7
Phoenix 7
Quito 7
Toronto 7
Boston 6
Campinas 6
Detroit 6
Porto Alegre 6
Pune 6
Tashkent 6
Vienna 6
Auburn Hills 5
Brasília 5
Brooklyn 5
Cape Town 5
Fortaleza 5
Fuzhou 5
Guayaquil 5
Hangzhou 5
Indiana 5
Kunming 5
Ribeirão Preto 5
Saint Petersburg 5
Totale 31.341
Salva come PNG Salva come JPEG
Nome #
Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay 600
Role of individual's T cell immunome in controlling HIV-1 progression 599
Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study 554
B-Pred, a structure based B-cell epitopes prediction server 536
HLA-A, -B and -DRB1 allele frequencies in Cyrenaica population (Libya) and genetic relationships with other populations 520
Neonatal protection and preterm birth reduction following maternal group B streptococcus vaccination in a mouse model 510
Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection 505
Design of immunogenic peptides from Mycobacterium tuberculosis genes expressed during macrophage infection 491
HS1,2 Ig Enhancer Alleles Association to AIDS Progression in a Pediatric Cohort Infected with a Monophyletic HIV-Strain 488
Delayed early antiretroviral treatment is associated with an HIV-specific long-term cellular response in HIV-1 vertically infected infants 480
Molecular epidemiology and phylogenetic analysis of Hepatitis B virus in a group of migrants in Italy 479
Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages: early membrane modifications and intracellular mycobacterial viability 475
A model of phenotypic susceptibility to tuberculosis: Deficient in silico selection of Mycobacterium tuberculosis epitopes by HLA alleles 470
An outbreak of Q fever in Bulgaria 463
M. avium binding to HLA-DR expressed alleles in silico: A model of phenotypic susceptibility to sarcoidosis 457
HFE gene variants and iron-induced oxygen radical generation in idiopathic pulmonary fibrosis 457
Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak 452
Amino Acid Mutations in Ebola Virus Glycoprotein of the 2014 epidemic 452
Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity 451
Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69 447
Optimizing Escherichia coli as a protein expression platform to produce Mycobacterium tuberculosis immunogenic proteins 444
Metodo per la diagnosi in vitro di fibrosi polmonare/polmonite interstiziale idiopatica e uso di chelanti del ferro per il trattamento della fibrosi polmonare/polmonite interstiziale idiopatica 443
Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study 439
HIV replication leads to skewed maturation of CD8-positive T-cell responses in infected children 438
Expansion of pre-terminally differentiated CD8 T cells in chronic HIV-positive patients presenting a rapid viral rebound during structured treatment interruption 435
Role of the HLA-DP Glu 69 and the TNF-alpha TNF-alpha 2 gene markers in susceptibility to beryllium hypersensitivity 435
Human Leucocyte Antigen Class I Diversity among Human Immunodeficiency Virus Exposed Negative and Positive Children in Cameroon. 435
Cross-reactive CD4+ T cells against one immunodominant tumor-derived epitope in melanoma patients 433
Key role of human leukocyte antigen in modulating HIV progression: an overview of the possible applications. 432
Analysis of TNF-alpha promoter polymorphisms in the susceptibility to beryllium hypersensitivity 431
Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy 430
Impact of human leukocyte antigen polymorphisms in human immunodeficiency virus progression in a paediatric cohort infected with a mono-phyletic human immunodeficiency virus-1 strain 429
Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transport 429
Use of amino acid sequences from Mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom 427
Genetic diversity in Ebola virus: Phylogenetic and in silico structural studies of Ebola viral proteins 427
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection 426
HLA class II amino acid epitopes as susceptibility markers of sarcoidosis 425
Dynamics of the laboratory results in patients with pulmonary tuberculosis. 424
Levels of interleukin-15 in plasma may predict a favorable outcome of structured treatment interruption in patients with chronic human immunodeficiency virus infection 421
Evaluation of a western blot test as a potential screening tool for occupational exposure to Mycobacterium tuberculosis in health care workers 421
Reactivity to mycobacterial antigens by patients with Lofgren's syndrome as a model of phenotypic susceptibility to disease and disease progression. 419
Association of age with the level of response in the QuantiFERON-TB Gold In-Tube assay for children with active tuberculosis 418
Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test 418
Immunoinformatic docking approach for the analysis of KIR3DL1/HLA-B interaction 414
Immunogenetic basis of environmental lung disease: Lessons from the berylliosis model 413
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 410
Beryllium disease 410
Computer-based design of an HLA-haplotype and HIV-clade independent cytotoxic T-lymphocyte assay for monitoring HIV-specific immunity 407
Evaluation of the BDProbeTec strand displacement amplification assay in comparison with the AMTD II direct test for rapid diagnosis of tuberculosis 407
Use of discriminant analysis to assess disease activity in pulmonary tuberculosis with a panel of specific and nonspecific serum markers 400
Uso di peptidi marcatori di sopravvivenza di Mycobacterium tuberculosis per la diagnosi e la prevenzione di infezione tubercolare e relativo kit diagnostico. 400
IGRAs for tuberculosis in sarcoidosis patients: is the immune response to mycobacteria helpful in the differential diagnosis or still a confounding factor? 398
HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells 398
Evaluation of a novel tuberculosis complex-specific 34 kDa protein in the serological diagnosis of tuberculosis 398
Different cytokine production and effector/memory dynamics of alpha beta+ or gamma delta+ T-cell subsets in the peripheral blood of patients with active pulmonary tuberculosis 398
Role of HLA-B α-3 domain amino acid position 194 in HIV disease progression 396
Proinflammatory cytokines in the course of Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages 390
Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection 389
Peptidi antigenici per uso diagnostico e di vaccinazione anti-tubercolare 389
Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak 388
Metal-induced diffuse lung disease 386
Antibody repertoire against the A60 antigen complex during the course of pulmonary tuberculosis 383
[Berylliosis in Italy: a case of "sarcoidosis" under the threshold limit value] 383
Sensitivity and specificity of a multi-antigen ELISA test for the serological diagnosis of tuberculosis 382
Synthetic peptides for use in the diagnosis and therapy of chronic granulomatous beryllium disease 381
Method of antigenic peptide identification and relative use for the preparation of a vaccine anti HIV-1 380
[Mycobacterium tuberculosis. From the gene to the diagnosis] 378
Uso di sequenze amminoacidiche da Mycobacterium tuberculosis o dei loro corrispondenti acidi nucleici per la diagnosi e la prevenzione di infezione tubercolare, relativo kit diagnostico e vaccino 377
Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding 377
Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis 376
Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69 374
Early abnormalities of the antibody response against Mycobacterium tuberculosis in human immunodeficiency virus infection 372
Evaluation of a multi-antigen test based on B-cell epitope peptides for the serodiagnosis of pulmonary tuberculosis 371
Major histocompatibility locus genetic markers of beryllium sensitization and disease 366
Seroprevalence of Ebola virus infection in Bombali district, Sierra Leone 365
Serological markers predicting tuberculosis in human immunodeficiency virus-infected patients 361
Rapid immunological test for the diagnosis and monitoring of tuberculosis infection. 361
Inactivation of polymerase inhibitors for Mycobacterium tuberculosis DNA amplification in sputum by using capture resin 359
Method for in vitro diagnosis of idiopathic pulmonary fibrosis 348
Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells 343
Evaluation of a western blot serum test for the diagnosis of Mycobacterium tuberculosis infection 339
Rational use of immunodiagnostic tools for tuberculosis infection: guidelines and cost effectiveness studies. 338
T cell recognition in chronic beryllium disease 329
Function associated transforming growth factor-beta gene polymorphism in chronic beryllium disease 319
QuantiFERON-TB performance enhanced by novel Mycobacterium tuberculosis-specific antigens. 317
Metodo e test diagnostici basati sull’analisi citofluorimetrica dei linfociti T antigene-specifici. 277
Occurrence of Legionella in showers at recreational facilities 207
Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns 137
Current use and acceptability of novel diagnostic tests for active tuberculosis: A worldwide survey|Uso atual e aceitabilidade de novos testes diagnósticos para tuberculose ativa: Um inquérito mundial 128
Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation 67
Totale 36.451
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.451
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.451
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021307 0 0 0 0 0 0 0 0 0 83 187 37
2021/2022790 30 82 22 59 21 92 43 40 52 59 65 225
2022/2023867 104 55 29 104 67 242 91 40 71 1 43 20
2023/2024289 47 6 16 12 17 101 7 2 21 4 2 54
2024/20252.043 80 424 214 91 40 75 153 101 202 149 279 235
2025/20262.667 247 174 385 275 240 95 287 346 403 215 0 0
Totale 36.451